GALD
Galderma Group N
Stock SIX Swiss Exchange – Stock Market Prices, News & Analysis
Galderma is a pharmaceutical company specializing in dermatological products, skin care, aesthetic medicines, and medical treatments related to dermatology.
Galderma Group N
GALD
Galderma is a pharmaceutical company specializing in dermatological products, skin care, aesthetic medicines, and medical treatments related to dermatology.
Price history of Galderma Group N
Price history of Galderma Group N
Performance & Momentum
Strategic Analysis
Galderma Group N • 2026
Galderma is a global player specializing in dermatology, positioned at the intersection of pharmaceuticals, skincare, and medical aesthetic treatments. Its business model is built on brands and solutions with strong clinical expertise, in a market where differentiation through innovation, prescription support, and medical trust is key.
- Niche positioning in dermatology and skincare, with expertise that is difficult to replicate quickly
- Exposure to attractive segments combining medical use, aesthetics, and recurring consumer demand
- Very strong stock market momentum, reflecting high investor confidence in execution quality and the growth profile
- Valuation may already reflect much of the good news after a sharp rise in the share price
- Dependence on competitive markets where innovation, brand strength, and margin preservation require ongoing execution
Momentum is very strong and reflects a pronounced uptrend, supported by sustained outperformance across multiple time frames. Strategically, this places Galderma among the most straightforward growth stories in the healthcare sector, but also among those where delivery must remain strong to justify further re-rating.
Similar stocks to Galderma Group N
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
